Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Thermo Fisher Scientific announced earnings per share of $7.21 on revenue of $9.91B. Analysts polled by Investing.com anticipated EPS of $6.67 on revenue of $9.72B.
Thermo Fisher Scientific shares are up 4% from the beginning of the year, still down 8.78% from its 52 week high of $532.57 set on November 6, 2020. They are under-performing the S&P 500 which is up 11.37% from the start of the year.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
Thermo Fisher Scientific's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar